ArticleJournal of neuro-oncology2016

Initial evidence that blood-borne microvesicles are biomarkers for recurrence and survival in newly diagnosed glioblastoma patients.

Sydney M Evans et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.